EN DE

Shandong Polymer Biochemicals Co (002476) Fair Value & Analysis

Basic Materials · CN · Market cap 3.3B CNY

SP Shandong Polymer Biochemicals Co 002476 · SHE
Price¥4.52
Fair Value¥0.8700
Upside-80.8%
Quality60/100
Watch Shandong Polymer Biochemicals Co for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Thin margins · 4.3% net margin
Low debt · generates free cash flow
Trails peers (4/14)
Narrow moat 32/100
Evidence: High Range ¥0.6500 – ¥1.09 Share as image

Fair value as of: Jul 22, 2026

From 25 valuation models · updated 19 days ago

Fair value updated Jul 22, 2026, revised from ¥1.21 to ¥0.8700 (−28.1%) since Jun 25, 2026. Share price −1.1% over the past month.

A solid business, but screening 81% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥1.09). The favourable scenario is already priced in.
  • Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥7.88 ¥3.26 Fair Value ¥0.8700 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range ¥3.26 – ¥7.88 · fair‑value band ¥0.6500 – ¥1.09 · the ¥4.52 price screens above the ¥0.8700 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Shandong Polymer Biochemicals Co (002476) currently trades at ¥4.52, while our model-based Fair Value estimate is ¥0.8700, implying the stock looks roughly 80.8% overvalued today. The Quality Score stands at 60/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Shandong Polymer Biochemicals Co generated revenue of 703M CNY at a net margin of 4.3%. Revenue grew 78.0% year over year. It earns a return on equity of 3.2%. The balance sheet holds a net cash position of 398M CNY. Fundamentals as of Jul 22, 2026

Our scenario range runs from ¥0.6500 (bear case) to ¥1.09 (bull case); at ¥4.52, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 43% below its 52-week high, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -46% fair-value upside, at -81%, 002476 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF ¥0.8800 ¥0.9100 ¥0.9600 80
Residual Income ¥1.11 ¥1.08 ¥0.9100 76
ROIC Compounder ¥1.11 ¥1.16 ¥1.20 72
All 25 models by family
DCF Models
FCF DCF ¥0.8800 ¥0.9200 ¥0.9700 38
Owner Earnings ¥1.28 ¥1.51 ¥1.84 31
5Y Revenue Exit ¥1.06 ¥1.26 ¥1.51 39
5Y EBITDA Exit ¥1.14 ¥1.40 ¥1.70 41
5Y P/E Exit ¥1.19 ¥1.49 ¥1.81 38
10Y Revenue Exit ¥0.9800 ¥1.14 ¥1.36 36
10Y EBITDA Exit ¥1.04 ¥1.23 ¥1.49 37
10Y P/E Exit ¥1.07 ¥1.30 ¥1.57 35
Earnings-Based
Graham-Dodd ¥0.3500 ¥0.9600 ¥1.26 54
Lynch FV ¥0.1900 ¥0.2700 ¥0.3600 50
PEG = 1.0 ¥0.1900 ¥0.2700 ¥0.3600 46
EPV ¥1.11 ¥1.16 ¥1.20 59
Dividend Discount
Gordon GGM ¥0.1100 ¥0.2200 ¥0.3300 70
DDM Multi-Stage ¥0.1100 ¥0.1700 ¥0.2300 61
Multiples
P/E Multiple ¥0.6500 ¥0.8700 ¥1.09 63
P/S Multiple ¥0.6500 ¥0.8700 ¥1.09 58
P/B Multiple ¥0.6500 ¥0.8700 ¥1.09 55
EV/EBIT ¥1.25 ¥1.40 ¥1.56 53
EV/EBITDA ¥1.35 ¥1.54 ¥1.72 54
EV/Revenue ¥1.19 ¥1.36 ¥1.53 43
Asset-Based
NCAV (Graham) ¥0.7800 ¥1.04 ¥1.55 50
Growth DCF
Growth DCF ¥0.8800 ¥0.9100 ¥0.9600 80
Economic Profit
Residual Income ¥1.11 ¥1.08 ¥0.9100 76
ROIC Compounder ¥1.11 ¥1.16 ¥1.20 72
Growth Earnings
Growth-Adj P/E ¥0.5300 ¥0.7600 ¥0.9800 68

Widest divergence: DCF Models (¥1.26) versus Dividend Discount (¥0.1700). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) 703M CNY
Revenue growth (YoY) +78.0%
Net margin 4.3%
Return on equity 3.2%
Free cash flow 4.7M CNY FY2025
P/E ratio 108.6
More key figures
Operating margin 6.0%
EPS (TTM) ¥0.0500
EPS growth (YoY) -9.5%
Net cash 398M CNY FY2024

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 60/100

Of which business quality 58 · Market factors (momentum, volatility) 34

Profitability 27
Margins and returns on capital today
Quality Growth 57
Are margins and returns improving?
Cashflow 17
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 87
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 22
Price trend over the last 3–12 months (market factor)
52W Momentum 14
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Shandong Polymer Biochemicals Co., Ltd., together with its subsidiaries, produces and sells chemicals for oil and gas exploitation in China and internationally. The company offers monomers, surface active agent, and polymers.

Full company description

Shandong Polymer Biochemicals Co., Ltd., together with its subsidiaries, produces and sells chemicals for oil and gas exploitation in China and internationally. The company offers monomers, surface active agent, and polymers. It also provides oil field stimulation and oil recovery technical services; and environmental protection water treatment products and technical services. The company was founded in 1996 and is headquartered in Dongying, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Shandong Polymer Biochemicals Co reported revenue of ¥603M in FY2025 versus ¥657M in FY2021, a compound −2.1%/yr. Reported net income was ¥31.3M in FY2025, compounding +14.9%/yr from FY2021.

Growth Quality 52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
603M CNY
Latest YoY
+12.0%
Avg. growth/yr (3Y)
+0.6%
Avg. growth/yr (5Y)
+6.2%
Avg. growth/yr (18Y)
+1.7%
Revenue −2.1%/yr
FY21 ¥657M
FY22 ¥592M
FY23 ¥387M
FY24 ¥539M
FY25 ¥603M
Net income +14.9%/yr
FY21 ¥17.9M
FY22 ¥29.7M
FY23 ¥5.2M
FY24 ¥56.4M
FY25 ¥31.3M

002476 screens 81% overvalued. Compare with BASF SE →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Shandong Polymer Biochemicals Co Fair Value". https://www.fairvalue-calculator.com/stock/002476

Peer Group

Chemicals · 334 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 60 · Above median
Fair Value upside −81% · Bottom 25%
Return on equity (TTM) 3% · Below median
Return on assets 2% · Below median
Net margin (TTM) 4% · Above median
Operating margin (TTM) 6% · Below median
Revenue growth 78% · Top 25%
Dividend yield (TTM) 0.0% · Bottom 25%
Debt / equity 0.01× · Lower than 75% of peers

Valuation Multiples vs Chemicals median · lower = cheaper

P/E (TTM) 108.6× · Pricier than 75% of peers
P/B 3.50× · Pricier than 75% of peers
P/S (TTM) 4.73× · Pricier than 75% of peers
P/FCF 104.7× · Pricier than 75% of peers
EV/EBITDA 61.1× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 100 · sector 20
PAST 13 · sector 19
HEALTH 100 · sector 94
DIVIDEND 0 · sector 27

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 532.13 MXN -49%
Ningxia Baofeng Energy Group 600989 ¥20.32 ¥20.17 -1%
Zhejiang Juhua Co 600160 ¥42.85 ¥23.35 -46%
PT Barito Pacific Tbk, BRPT 1,690 IDR 1,628 IDR -4%
LG Chem, Ltd 051910 260,500 KRW 587,755 KRW +126%
Formosa Chemicals & Fibre Corporation 1326 66.10 TWD 6.79 TWD -90%
PTT Global Chemical Public Company PTTGC 35.50 THB 18.21 THB -49%
542812 542812 ₹4,369 ₹791.05 -82%
Indorama Ventures Public Company IVL 24.50 THB 17.95 THB -27%
Navin Fluorine International Limited NAVINFLUOR ₹8,650 ₹2,146 -75%

Compare Shandong Polymer Biochemicals Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Shandong Polymer Biochemicals Co (002476) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of ¥0.8700 versus a price of ¥4.52, about −81% (overvalued).
What is the fair value of 002476?
Our model-based fair value for Shandong Polymer Biochemicals Co is ¥0.8700 (as of Jul 22, 2026), built from audited fundamentals. The current price is ¥4.52.
What is the quality score of 002476?
Shandong Polymer Biochemicals Co has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Shandong Polymer Biochemicals Co (002476)?
Shandong Polymer Biochemicals Co reported trailing-twelve-month revenue of about 703M CNY (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 002476?
The net profit margin of Shandong Polymer Biochemicals Co is about 4.3%, meaning it keeps roughly 4.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Shandong Polymer Biochemicals Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.